Florian Selt

5.0k total citations
16 papers, 251 citations indexed

About

Florian Selt is a scholar working on Genetics, Molecular Biology and Neurology. According to data from OpenAlex, Florian Selt has authored 16 papers receiving a total of 251 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Genetics, 9 papers in Molecular Biology and 5 papers in Neurology. Recurrent topics in Florian Selt's work include Glioma Diagnosis and Treatment (11 papers), Neuroblastoma Research and Treatments (5 papers) and Chromatin Remodeling and Cancer (3 papers). Florian Selt is often cited by papers focused on Glioma Diagnosis and Treatment (11 papers), Neuroblastoma Research and Treatments (5 papers) and Chromatin Remodeling and Cancer (3 papers). Florian Selt collaborates with scholars based in Germany, United Kingdom and United States. Florian Selt's co-authors include Till Milde, Olaf Witt, Stefan M. Pfister, Martin Michaelis, Florian Rothweiler, Jonas Ecker, Jindřich Činátl, Cornelis M. van Tilburg, Felix Sahm and Marcel Kool and has published in prestigious journals such as PLoS ONE, Signal Transduction and Targeted Therapy and Neuro-Oncology.

In The Last Decade

Florian Selt

12 papers receiving 246 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Florian Selt Germany 8 149 109 102 57 37 16 251
Owen Clark United Kingdom 5 132 0.9× 53 0.5× 28 0.3× 45 0.8× 85 2.3× 5 232
Edward Favours United States 7 216 1.4× 29 0.3× 58 0.6× 91 1.6× 29 0.8× 10 290
Radhika Peddinti United States 8 130 0.9× 44 0.4× 92 0.9× 51 0.9× 69 1.9× 21 270
Vy Ngo United States 5 289 1.9× 182 1.7× 70 0.7× 46 0.8× 84 2.3× 7 442
Junyi Yin China 7 147 1.0× 23 0.2× 28 0.3× 50 0.9× 90 2.4× 8 254
Nishita Thota Netherlands 4 71 0.5× 63 0.6× 13 0.1× 80 1.4× 31 0.8× 5 192
Bingwei Ye United States 9 250 1.7× 14 0.1× 63 0.6× 39 0.7× 162 4.4× 12 349
Tim van Groningen Netherlands 5 128 0.9× 15 0.1× 125 1.2× 71 1.2× 78 2.1× 7 214
Aimée du Chatinier Netherlands 6 98 0.7× 35 0.3× 16 0.2× 52 0.9× 17 0.5× 9 147
Lintong Li China 2 181 1.2× 17 0.2× 76 0.7× 127 2.2× 38 1.0× 4 292

Countries citing papers authored by Florian Selt

Since Specialization
Citations

This map shows the geographic impact of Florian Selt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Florian Selt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Florian Selt more than expected).

Fields of papers citing papers by Florian Selt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Florian Selt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Florian Selt. The network helps show where Florian Selt may publish in the future.

Co-authorship network of co-authors of Florian Selt

This figure shows the co-authorship network connecting the top 25 collaborators of Florian Selt. A scholar is included among the top collaborators of Florian Selt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Florian Selt. Florian Selt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Stefanski, Anja, Florian Selt, Daniel Picard, et al.. (2025). Multi-omics dissection of MAPK-driven senescence unveils therapeutic vulnerabilities in KIAA1549::BRAF-fusion pediatric low-grade glioma models. Signal Transduction and Targeted Therapy. 10(1). 197–197. 1 indexed citations
2.
Brummer, Tilman, et al.. (2024). MOST wanted: navigating the MAPK-OIS-SASP-tumor microenvironment axis in primary pediatric low-grade glioma and preclinical models. Child s Nervous System. 40(10). 3209–3221. 3 indexed citations
3.
Lenga, Pavlina, Daniel Kühlwein, Mohammed Issa, et al.. (2024). Decoding pediatric spinal tumors: a single-center retrospective case series on etiology, presentation, therapeutic strategies, and outcomes. Neurosurgical Review. 47(1). 557–557.
4.
Selt, Florian, Ahmed El Damaty, Martin U. Schuhmann, et al.. (2023). Generation of patient-derived pediatric pilocytic astrocytoma in-vitro models using SV40 large T: evaluation of a modeling workflow. Journal of Neuro-Oncology. 165(3). 467–478. 1 indexed citations
5.
Stefanski, Anja, Florian Selt, Thomas Hielscher, et al.. (2023). LGG-03. EXPLORING THE SIGNALING NETWORK INVOLVED IN MAPK PATHWAY INHIBITION BY THE MEK INHIBITOR TRAMETINIB IN BRAF-FUSION-DRIVEN PEDIATRIC PILOCYTIC ASTROCYTOMA. Neuro-Oncology. 25(Supplement_1). i55–i55.
6.
Selt, Florian, Stefan Pusch, Romain Guiho, et al.. (2022). LGG-17. Preventing recurrence: targeting molecular mechanisms driving tumor growth rebound after MAPKi withdrawal in pediatric low-grade glioma. Neuro-Oncology. 24(Supplement_1). i91–i91.
7.
Guiho, Romain, Florian Selt, T. J. Stone, et al.. (2021). LGG-09. SENOLYTIC AGENT NAVITOCLAX TARGETS VINBLASTINE- AND MAPK INHIBITORS-INDUCED SENESCENT TUMOUR CELLS IN PAEDIATRIC LOW GRADE GLIOMAS. Neuro-Oncology. 23(Supplement_1). i33–i33. 1 indexed citations
8.
Selt, Florian, Cornelis M. van Tilburg, Brigitte Bison, et al.. (2020). Response to trametinib treatment in progressive pediatric low-grade glioma patients. Journal of Neuro-Oncology. 149(3). 499–510. 68 indexed citations
9.
Capper, David, Olaf Witt, Till Milde, et al.. (2019). LGG-11. ESTABLISHMENT OF A HUMAN 3-DIMENSIONAL LOW-GRADE GLIOMA TUMOR MODEL IN INDUCED PLURIPOTENT STEM CELL DERIVED BRAIN ORGANOIDS. Neuro-Oncology. 21(Supplement_2). ii101–ii101. 1 indexed citations
10.
Ecker, Jonas, Dominik Sturm, Florian Selt, et al.. (2018). Molecular Diagnostics in Pediatric Brain Tumors: Impact on Diagnosis and Clinical Decision-Making — A Selected Case Series. Klinische Pädiatrie. 230(6). 305–313. 7 indexed citations
11.
Tilburg, Cornelis M. van, Florian Selt, Felix Sahm, et al.. (2017). Response in a child with a BRAF V600E mutated desmoplastic infantile astrocytoma upon retreatment with vemurafenib. Pediatric Blood & Cancer. 65(3). 18 indexed citations
12.
Schmidt, Christin, Sebastian Brabetz, Norman Mack, et al.. (2017). Preclinical drug screen reveals topotecan, actinomycin D, and volasertib as potential new therapeutic candidates for ETMR brain tumor patients. Neuro-Oncology. 19(12). 1607–1617. 31 indexed citations
13.
Michaelis, Martin, Florian Selt, Florian Rothweiler, Michael Wiese, & Jindřich Činátl. (2015). ABCG2 impairs the activity of the aurora kinase inhibitor tozasertib but not of alisertib. BMC Research Notes. 8(1). 484–484. 13 indexed citations
14.
Selt, Florian, Andrey Korshunov, David Capper, et al.. (2015). Pediatric Targeted Therapy: Clinical Feasibility of Personalized Diagnostics in Children with Relapsed and Progressive Tumors. Brain Pathology. 26(4). 506–516. 8 indexed citations
15.
Ecker, Jonas, Ina Oehme, Ralph Mazitschek, et al.. (2015). Targeting class I histone deacetylase 2 in MYC amplified group 3 medulloblastoma. Acta Neuropathologica Communications. 3(1). 22–22. 57 indexed citations
16.
Michaelis, Martin, Florian Selt, Florian Rothweiler, et al.. (2014). Aurora Kinases as Targets in Drug-Resistant Neuroblastoma Cells. PLoS ONE. 9(9). e108758–e108758. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026